In clinical trials, Evenity substantially increased bone density and prevented fractures more effectively than available treatments, according to the drug makers’ findings.
Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules.
A new wave of websites turns physicians into mere gatekeepers for popular lifestyle drugs, increasing public health risks, experts say. The sites say they ease connections with doctors.